{"title":"One-year outcomes of anterior–posterior vs. anterior-lateral method of cardioversion for atrial fibrillation: a tertiary center experience","authors":"Sarim Rashid, Syed Ahmed Salahuddin, Fatima Sajid, Syed Yasir Shah, Jahanzeb Malik, Saifullah Khan","doi":"10.1186/s42444-024-00111-y","DOIUrl":"https://doi.org/10.1186/s42444-024-00111-y","url":null,"abstract":"","PeriodicalId":34172,"journal":{"name":"International Journal of Arrhythmia","volume":"330 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140482940","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-23DOI: 10.1186/s42444-024-00109-6
Aritra Paul, Chadi Tabaja, O. Wazni
{"title":"SGLT2 inhibitors and the cardiac rhythm: unraveling the connections","authors":"Aritra Paul, Chadi Tabaja, O. Wazni","doi":"10.1186/s42444-024-00109-6","DOIUrl":"https://doi.org/10.1186/s42444-024-00109-6","url":null,"abstract":"","PeriodicalId":34172,"journal":{"name":"International Journal of Arrhythmia","volume":"61 17","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139602894","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-15DOI: 10.1186/s42444-023-00108-z
S. Saidullah, B. A. Ahmad, Muhammad Saad Waqas, Anam Fatima, Malik Hasnat ul Hassan Khan, Umer Khiyam, Jahanzeb Malik
{"title":"Sex-related differences of fatty acid-binding protein 4 and leptin levels in atrial fibrillation: an updated review","authors":"S. Saidullah, B. A. Ahmad, Muhammad Saad Waqas, Anam Fatima, Malik Hasnat ul Hassan Khan, Umer Khiyam, Jahanzeb Malik","doi":"10.1186/s42444-023-00108-z","DOIUrl":"https://doi.org/10.1186/s42444-023-00108-z","url":null,"abstract":"","PeriodicalId":34172,"journal":{"name":"International Journal of Arrhythmia","volume":" 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139622953","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-11-24DOI: 10.1186/s42444-023-00107-0
Sarim Rashid, Ritesh Pahwani, Sahil Raj, Hafiz Ahmed Raza Khan, Saffa Nadeem, Muhammad Usman Ghani, J. Basit, Amin Mehmoodi, Jahanzeb Malik
{"title":"Validation of arrhythmogenic right ventricular cardiomyopathy risk calculator for sudden cardiac death: a systematic review","authors":"Sarim Rashid, Ritesh Pahwani, Sahil Raj, Hafiz Ahmed Raza Khan, Saffa Nadeem, Muhammad Usman Ghani, J. Basit, Amin Mehmoodi, Jahanzeb Malik","doi":"10.1186/s42444-023-00107-0","DOIUrl":"https://doi.org/10.1186/s42444-023-00107-0","url":null,"abstract":"","PeriodicalId":34172,"journal":{"name":"International Journal of Arrhythmia","volume":"130 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139242263","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-11-09DOI: 10.1186/s42444-023-00106-1
Jongmin Hwang, Seongwook Han, Chun Hwang, Tae-Wan Chung, Hyoung-Seob Park
Abstract Background The muscular discontinuities or lack of myocardial extensions around the pulmonary veins (PVs) antrum were previously reported. The objective of our study was to compare the efficacy of a partial antral ablation for PV isolation (PVI) using ultra-high density (UHD) mapping with a conventional wide antral circumferential ablation (WACA) in atrial fibrillation (AF) patients. Methods A total of 119 patients medical records who received catheter ablation for AF in our hospital were analyzed. In one group of patients, detailed activation mapping of each PV was performed using a UHD mapping system. Each PV antral segment’s activation pattern was classified into “directly-activated from the LA” or “passively-activated from an adjacent PV segment” patterns. The ablation applications were performed at the directly-activated PV antral segment only for the PVI when the PV had “passively-activated segments” (partial antral ablation; PA-UHD group). Another patient group received a conventional WACA for the PVI (WACA group). Results Sixty patients received partial antral ablation (PA-UHD), and age/sex-matched 59 patients received WACA. In the PA-UHD group, passively-activated segments were observed in 58.3% of all PV segments. The success rate of a partial antral ablation for the PVI in PVs with passively-activated segments was 85%. The 1-year atrial tachyarrhythmia recurrence did not differ between the PA-UHD and WACA groups. Conclusions Our study revealed the presence of passively-activated PV segments, which could potentially indicate muscular discontinuity at the PV-LA junction. In most PVs with passively-activated segments, PVI was successfully achieved by ablation with only directly-activated segments. The 1-year recurrence rate of atrial tachyarrhythmia in PA-UHD group was comparable to that observed in the WACA group.
{"title":"The efficacy of ultra-high-density mapping guided partial antral ablation for pulmonary vein isolation in atrial fibrillation patients","authors":"Jongmin Hwang, Seongwook Han, Chun Hwang, Tae-Wan Chung, Hyoung-Seob Park","doi":"10.1186/s42444-023-00106-1","DOIUrl":"https://doi.org/10.1186/s42444-023-00106-1","url":null,"abstract":"Abstract Background The muscular discontinuities or lack of myocardial extensions around the pulmonary veins (PVs) antrum were previously reported. The objective of our study was to compare the efficacy of a partial antral ablation for PV isolation (PVI) using ultra-high density (UHD) mapping with a conventional wide antral circumferential ablation (WACA) in atrial fibrillation (AF) patients. Methods A total of 119 patients medical records who received catheter ablation for AF in our hospital were analyzed. In one group of patients, detailed activation mapping of each PV was performed using a UHD mapping system. Each PV antral segment’s activation pattern was classified into “directly-activated from the LA” or “passively-activated from an adjacent PV segment” patterns. The ablation applications were performed at the directly-activated PV antral segment only for the PVI when the PV had “passively-activated segments” (partial antral ablation; PA-UHD group). Another patient group received a conventional WACA for the PVI (WACA group). Results Sixty patients received partial antral ablation (PA-UHD), and age/sex-matched 59 patients received WACA. In the PA-UHD group, passively-activated segments were observed in 58.3% of all PV segments. The success rate of a partial antral ablation for the PVI in PVs with passively-activated segments was 85%. The 1-year atrial tachyarrhythmia recurrence did not differ between the PA-UHD and WACA groups. Conclusions Our study revealed the presence of passively-activated PV segments, which could potentially indicate muscular discontinuity at the PV-LA junction. In most PVs with passively-activated segments, PVI was successfully achieved by ablation with only directly-activated segments. The 1-year recurrence rate of atrial tachyarrhythmia in PA-UHD group was comparable to that observed in the WACA group.","PeriodicalId":34172,"journal":{"name":"International Journal of Arrhythmia","volume":" 7","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135241396","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-10-23DOI: 10.1186/s42444-023-00105-2
Hee-Jin Kwon, Dong Seop Jeong, Seung-Jung Park, Kyoung-Min Park, June Soo Kim, Young Keun On
Abstract Background In patients with non-paroxysmal AF (atrial fibrillation), various ablation strategies have been attempted to target non-pulmonary vein (PV) foci or to achieve substrate modification beyond pulmonary vein isolation. The efficacy of empirical ablation of the SVC, one of the most common non-PV foci, is unclear. The aim of this study was to investigate the efficacy and safety of additional superior vena cava (SVC) isolation in patients with non-paroxysmal AF undergoing thoracoscopic surgical ablation. Methods/results A total of 191 patients with persistent or long-standing persistent AF was enrolled. All patients underwent total thoracoscopic surgical ablation for AF, and half of them also received empirical SVC isolation. We compared the atrial tachyarrhythmia (ATa)-free survival rate and procedure-related complications in the two groups of patients. The 3-year ATa-free survival rate was 53% in the SVC isolation group and 52% in the no-SVC isolation group ( p = 0.644). There were no differences between the two groups with respect to AF type or LA size. Procedure-related complications occurred in 12 patients (6%). Pacemakers were implanted only in three patients from the SVC isolation group. The only factor influencing recurrence of ATa was LA diameter. Conclusions Empirical SVC isolation during thoracoscopic ablation for persistent AF did not improve patient outcomes.
{"title":"The effect of empirical superior vena cava isolation during total thoracoscopic ablation in patients with persistent atrial fibrillation","authors":"Hee-Jin Kwon, Dong Seop Jeong, Seung-Jung Park, Kyoung-Min Park, June Soo Kim, Young Keun On","doi":"10.1186/s42444-023-00105-2","DOIUrl":"https://doi.org/10.1186/s42444-023-00105-2","url":null,"abstract":"Abstract Background In patients with non-paroxysmal AF (atrial fibrillation), various ablation strategies have been attempted to target non-pulmonary vein (PV) foci or to achieve substrate modification beyond pulmonary vein isolation. The efficacy of empirical ablation of the SVC, one of the most common non-PV foci, is unclear. The aim of this study was to investigate the efficacy and safety of additional superior vena cava (SVC) isolation in patients with non-paroxysmal AF undergoing thoracoscopic surgical ablation. Methods/results A total of 191 patients with persistent or long-standing persistent AF was enrolled. All patients underwent total thoracoscopic surgical ablation for AF, and half of them also received empirical SVC isolation. We compared the atrial tachyarrhythmia (ATa)-free survival rate and procedure-related complications in the two groups of patients. The 3-year ATa-free survival rate was 53% in the SVC isolation group and 52% in the no-SVC isolation group ( p = 0.644). There were no differences between the two groups with respect to AF type or LA size. Procedure-related complications occurred in 12 patients (6%). Pacemakers were implanted only in three patients from the SVC isolation group. The only factor influencing recurrence of ATa was LA diameter. Conclusions Empirical SVC isolation during thoracoscopic ablation for persistent AF did not improve patient outcomes.","PeriodicalId":34172,"journal":{"name":"International Journal of Arrhythmia","volume":"17 6","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135368299","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-10-01DOI: 10.1186/s42444-023-00104-3
Cody Carter, Zeryab Khan, Rayan El-Zein, Marie Lockhart, Ankur Shah, David Nemer, Jaret Tyler, Eugene Fu, Auroa Badin, Sreedhar R. Billakanty, Anish K. Amin, Nagesh Chopra
Abstract Background Reactive atrial-based anti-tachycardia pacing (rATP) in CIED (cardiovascular implantable electronic devices) is effective in atrial fibrillation (AF) suppression. Uninterrupted systemic anticoagulation is recommended when this algorithm is activated to avoid stroke, however, the use of a rATP algorithm in patients with a left atrial appendage (LAA) closure device has not been studied. We assessed the safety and feasibility of rATP algorithm to suppress AF in patients with a LAA closure device over an extended period. Methods Data from 55 consecutive patients who underwent a Watchman ® implant at a tertiary care hospital between September 1, 2015, and January 30, 2020, who also had an in situ Medtronic ® CIED (45 with and 10 without rATP capability) were retrospectively reviewed. Results The 55-patient cohort was 60% male, 77 ± 8 years old, CHA 2 DS 2 -VASc score 5 (4–6), HAS-BLED score 3 (3–4), LVEF 53 ± 14%, LA size 4.4 ± 0.7 cm and ventricular pacing burden of 73 (1.4–98.3)%. The CIEDs (20 ICDs and 35 pacemakers) antedated Watchman ® implants by 915 ± 725 days. Post-implant, all patients discontinued anticoagulation. Twenty patients in the rhythm-control group with active rATP algorithm displayed no increase in yearly AF burden and were less likely to develop permanent/long-standing persistent AF ( p = 0.002) when compared to 35 patients in the rate-control group with CIEDs inactive/incapable of rATP over a ≤ 5-year follow-up. The longest AF episode in the rhythm-control group lasted 204 (19–2520) h. There was no increase in stroke/thromboembolism and a significant reduction in major bleeding noted over ≤ 5 years pre- versus post-implant in the whole cohort ( p = 0.005). Conclusion rATP algorithm use is safe and feasible in patients with a Watchman ® device. Patients should be forewarned of a surge in post-Watchman ® implant AF burden.
{"title":"Reactive atrial-based anti-tachycardia pacing algorithm in cardiovascular implantable electronic devices is safe and feasible without increase in thromboembolic events in patients with a left atrial appendage closure device","authors":"Cody Carter, Zeryab Khan, Rayan El-Zein, Marie Lockhart, Ankur Shah, David Nemer, Jaret Tyler, Eugene Fu, Auroa Badin, Sreedhar R. Billakanty, Anish K. Amin, Nagesh Chopra","doi":"10.1186/s42444-023-00104-3","DOIUrl":"https://doi.org/10.1186/s42444-023-00104-3","url":null,"abstract":"Abstract Background Reactive atrial-based anti-tachycardia pacing (rATP) in CIED (cardiovascular implantable electronic devices) is effective in atrial fibrillation (AF) suppression. Uninterrupted systemic anticoagulation is recommended when this algorithm is activated to avoid stroke, however, the use of a rATP algorithm in patients with a left atrial appendage (LAA) closure device has not been studied. We assessed the safety and feasibility of rATP algorithm to suppress AF in patients with a LAA closure device over an extended period. Methods Data from 55 consecutive patients who underwent a Watchman ® implant at a tertiary care hospital between September 1, 2015, and January 30, 2020, who also had an in situ Medtronic ® CIED (45 with and 10 without rATP capability) were retrospectively reviewed. Results The 55-patient cohort was 60% male, 77 ± 8 years old, CHA 2 DS 2 -VASc score 5 (4–6), HAS-BLED score 3 (3–4), LVEF 53 ± 14%, LA size 4.4 ± 0.7 cm and ventricular pacing burden of 73 (1.4–98.3)%. The CIEDs (20 ICDs and 35 pacemakers) antedated Watchman ® implants by 915 ± 725 days. Post-implant, all patients discontinued anticoagulation. Twenty patients in the rhythm-control group with active rATP algorithm displayed no increase in yearly AF burden and were less likely to develop permanent/long-standing persistent AF ( p = 0.002) when compared to 35 patients in the rate-control group with CIEDs inactive/incapable of rATP over a ≤ 5-year follow-up. The longest AF episode in the rhythm-control group lasted 204 (19–2520) h. There was no increase in stroke/thromboembolism and a significant reduction in major bleeding noted over ≤ 5 years pre- versus post-implant in the whole cohort ( p = 0.005). Conclusion rATP algorithm use is safe and feasible in patients with a Watchman ® device. Patients should be forewarned of a surge in post-Watchman ® implant AF burden.","PeriodicalId":34172,"journal":{"name":"International Journal of Arrhythmia","volume":"6 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135406619","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-09-15DOI: 10.1186/s42444-023-00102-5
Ga-In Yu, Daehoon Kim, Hee Tae Yu, Tae-Hoon Kim, Il-Young Oh, Jong Sung Park, Hyung-Seob Park, Junbeom Park, Young Soo Lee, Ki-Woon Kang, Jaemin Shim, Jung-Hoon Sung, Eue-Keun Choi, Boyoung Joung
Abstract Background It has become important to identify and manage risk factors for subclinical atrial fibrillation (AF) with an increase in its detection rate. Thus, this research aimed to investigate whether alcohol consumption contributes to the development of subclinical AF. Methods This prospective study enrolled 467 patients without AF from a multicenter pacemaker registry. The incidence of subclinical AF (episodes of atrial rate > 220 beats per minute without symptoms) was compared between alcohol-drinking and non-drinking groups. Results During followup (median 18 months), the incidence and risk of long-duration atrial high-rate episodes (AHRE) ≥ 24 h were increased in the alcohol group compared to the non-alcohol group [5.47 vs. 2.10 per 100 person-years, adjusted hazard ratio (HR), 2.83; 95% confidence interval (CI), 1.14–7.04; P = 0.03]. After propensity score matching, the incidence and risk of long-duration AHRE were higher in the alcohol group (6.97 vs. 1.27 per 100 person-years, adjusted HR, 7.84; 95% CI, 1.21–50.93; P = 0.03). The mean burden of long-duration subclinical AF was higher in the alcohol group than in the non-alcohol group (0.18 vs. 1.61% during follow-up, P = 0.08). Conclusion Alcohol consumption was associated with an increased risk of subclinical AF. Long-duration AHRE incidence and AHRE burden were higher in alcohol drinkers than in non-drinkers.
背景随着亚临床心房颤动(AF)检出率的提高，识别和管理其危险因素变得越来越重要。因此，本研究旨在探讨饮酒是否与亚临床房颤的发展有关。方法本前瞻性研究纳入了来自多中心起搏器登记的467例无房颤患者。亚临床房颤发生率(房颤发作率>在饮酒组和不饮酒组之间比较每分钟220次(无症状)。结果在随访期间(中位18个月)，与非酒精组相比，酒精组≥24 h的长时间心房高率发作(AHRE)的发生率和风险增加[5.47 vs 2.10 / 100人年，校正风险比(HR)， 2.83;95%置信区间(CI)， 1.14-7.04;P = 0.03]。倾向评分匹配后，酒精组长期AHRE的发生率和风险更高(6.97 vs 1.27 / 100人年，调整后HR为7.84;95% ci, 1.21-50.93;P = 0.03)。酒精组长期亚临床房颤的平均负担高于非酒精组(随访期间为0.18比1.61%，P = 0.08)。结论:饮酒与亚临床房颤风险增加相关。饮酒者的长期AHRE发病率和AHRE负担高于非饮酒者。
{"title":"Association between alcohol consumption and subclinical atrial fibrillation","authors":"Ga-In Yu, Daehoon Kim, Hee Tae Yu, Tae-Hoon Kim, Il-Young Oh, Jong Sung Park, Hyung-Seob Park, Junbeom Park, Young Soo Lee, Ki-Woon Kang, Jaemin Shim, Jung-Hoon Sung, Eue-Keun Choi, Boyoung Joung","doi":"10.1186/s42444-023-00102-5","DOIUrl":"https://doi.org/10.1186/s42444-023-00102-5","url":null,"abstract":"Abstract Background It has become important to identify and manage risk factors for subclinical atrial fibrillation (AF) with an increase in its detection rate. Thus, this research aimed to investigate whether alcohol consumption contributes to the development of subclinical AF. Methods This prospective study enrolled 467 patients without AF from a multicenter pacemaker registry. The incidence of subclinical AF (episodes of atrial rate > 220 beats per minute without symptoms) was compared between alcohol-drinking and non-drinking groups. Results During followup (median 18 months), the incidence and risk of long-duration atrial high-rate episodes (AHRE) ≥ 24 h were increased in the alcohol group compared to the non-alcohol group [5.47 vs. 2.10 per 100 person-years, adjusted hazard ratio (HR), 2.83; 95% confidence interval (CI), 1.14–7.04; P = 0.03]. After propensity score matching, the incidence and risk of long-duration AHRE were higher in the alcohol group (6.97 vs. 1.27 per 100 person-years, adjusted HR, 7.84; 95% CI, 1.21–50.93; P = 0.03). The mean burden of long-duration subclinical AF was higher in the alcohol group than in the non-alcohol group (0.18 vs. 1.61% during follow-up, P = 0.08). Conclusion Alcohol consumption was associated with an increased risk of subclinical AF. Long-duration AHRE incidence and AHRE burden were higher in alcohol drinkers than in non-drinkers.","PeriodicalId":34172,"journal":{"name":"International Journal of Arrhythmia","volume":"203 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135355104","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-09-01DOI: 10.1186/s42444-023-00101-6
Mingliang Tan, Y. H. Yeo, Boon Jian San, J. Tan
{"title":"Trends in cardiovascular death related to mechanical complications of cardiac electronic devices in the United States from 1999 to 2020","authors":"Mingliang Tan, Y. H. Yeo, Boon Jian San, J. Tan","doi":"10.1186/s42444-023-00101-6","DOIUrl":"https://doi.org/10.1186/s42444-023-00101-6","url":null,"abstract":"","PeriodicalId":34172,"journal":{"name":"International Journal of Arrhythmia","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43712367","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-08-22DOI: 10.1186/s42444-023-00103-4
D. Jeong
{"title":"Current methods of left atrial appendage closure: the non-pharmacological approach for stroke prevention in atrial fibrillation patients","authors":"D. Jeong","doi":"10.1186/s42444-023-00103-4","DOIUrl":"https://doi.org/10.1186/s42444-023-00103-4","url":null,"abstract":"","PeriodicalId":34172,"journal":{"name":"International Journal of Arrhythmia","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49005477","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：